Clinical Trials
TROPICS
- Immune System
Characterization of SSc-ILD patients and linkage to clinical outcomes
- Ages18 years and older
- GenderBoth
- Skin/Dermatology, Immune System
Genome Research in African American Scleroderma Patients (GRASP Study)
- Ages18 years and older
- GenderBoth
- Skin/Dermatology, Orthopaedics, Muscle & Bone
The Scleroderma Patient-centered Intervention Network (SPIN)
- Ages18 years and older
- GenderBoth
- Orthopaedics, Muscle & Bone
SSc Arm Fat Quantification Study
- Orthopaedics, Muscle & Bone
Phase III Study to Evaluate the Safety and Efficacy of Anifrolumab Compared with Placebo in Male and Female Participants 18 to 70 Years of Age Inclusive with Systemic Sclerosis
- Ages18 years - 70 years
- GenderBoth
- Immune System
Pathogenic Wnt-beta catenin target genes in macrophages and fibrosis